Home › Free Stock Grades › CDNA
CareDx, Inc (CDNA) Stock Grade
CDNA · Healthcare
B+
Market Cap
$1.0B
P/E Ratio
—
Revenue Growth (YoY)
+13.8%
Net Margin
-5.6%
Return on Equity
—
Dividend Yield
None
About CareDx, Inc's fundamentals
CareDx is a healthcare diagnostics company with a market capitalization of $1.0 billion that has demonstrated revenue growth of 13.8% year-over-year, indicating expansion in its core business. However, the company is currently unprofitable, reporting a net loss with a net margin of -5.6% in its latest annual statement. Despite the accounting losses, CareDx has generated positive free cash flow, suggesting the company is converting some operational activities into cash despite its bottom-line losses. The company does not pay a dividend to shareholders.